Spectrum Pharmaceuticals, Inc.
Officials from Spectrum Pharmaceuticals, Inc., report on recent activities
Published in Health Business Week, October 12th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Spectrum Pharmaceuticals, Inc.
Report 1: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) announced that the United States Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA should wait for the overall survival analysis of satraplatin.
"We have confidence the final data analysis of overall survival will demonstrate the efficacy and safety of satraplatin for the treatment of hormone-refractory prostate...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-10-12)
More Articles from Health Business Week
- 24 Hour Fitness
Yao Ming, Jackie Chan and All-Star Cast Celebrate California Fitness - Yao Ming Sport Club Grand Opening in Beijing - A Place for Mom
A Place for Mom COO Makes Seattle's 40 Under 40 List - AARP
Post-Debate Statement From AARP Spokesperson Drew Nannis - AARP Maryland
AARP Maryland Calls on President Bush Not to Veto SCHIP - AARP Pennsylvania
Saint Vincent Health System of Erie, Pennsylvania Named One of AARP 2007 Best Employers for Workers Over 50 - Abbott
Abbott Again Honored as Top Company for Working Moms - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
